Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome - Université de Bretagne Occidentale Access content directly
Journal Articles New England Journal of Medicine Year : 2018

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Gregory Schwartz
P. Gabriel Steg
  • Function : Author
Michael Szarek
  • Function : Author
Deepak Bhatt
Vera Bittner
  • Function : Author
Jay Edelberg
  • Function : Author
Shaun Goodman
  • Function : Author
Corinne Hanotin
  • Function : Author
Robert Harrington
  • Function : Author
Kenneth Mahaffey
  • Function : Author
Angèle Moryusef
  • Function : Author
Robert Pordy
  • Function : Author
Kirby Quintero
  • Function : Author
Matthew Roe
  • Function : Author
William Sasiela
  • Function : Author
Jean-François Tamby
  • Function : Author
Pierluigi Tricoci
  • Function : Author
Harvey White
  • Function : Author
Andreas Zeiher
  • Function : Author
Jacques Mansourati

Dates and versions

hal-02059074 , version 1 (06-03-2019)

Identifiers

Cite

Gregory Schwartz, P. Gabriel Steg, Michael Szarek, Deepak Bhatt, Vera Bittner, et al.. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome. New England Journal of Medicine, 2018, 379 (22), pp.2097-2107. ⟨10.1056/NEJMoa1801174⟩. ⟨hal-02059074⟩

Collections

UNIV-BREST
26 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More